Search Results for 'biopharma'

Search For:
Refine by Dates:
From: To:
Refine By Content:

  • India’s Pharmaceutical Industry Outlook

    India’s Pharmaceutical Industry Outlook

    Dr. Gurpreet Sandhu, Reva Pharmachem || March 6, 2015
    Market predicted to be worth $50B by 2020

  • Ajinomoto Althea Inc.

    Ajinomoto Althea Inc.

    Kristi Woolery, Marketing Strategist || October 22, 2014
    .green {background-color:#232c65;color:#ffffff;height:22px;text-align:center;padding-top:2px;width:770px;} .dark {font-weight:bold;text-align:center;} .green a, .green a:hover {text-decoration:none;color:#ffffff;} Who We Are…

  • Injectables CMOs Stay Ahead of Complexity

    Injectables CMOs Stay Ahead of Complexity

    Kristin Brooks , Contract Pharma || April 3, 2014
    Biologics and cytotoxic processes are pushing demand for specialized contract services, especially from small-to-midsized companies.

  • Hetero USA Inc.

    Hetero USA Inc.

    Paul Sidhu, Vice President || December 5, 2013
    Hetero is the largest privately held pharmaceutical company in India. Hetero is the largest producer of Anti-Retroviral drugs and has 9 FDA-approved manufacturing plants. Hetero’s vertical integration and new facilities, as well as ambition for…

  • CRO Outlook & Market Trends

    CRO Outlook & Market Trends

    Kristin Brooks, Contract Pharma || June 5, 2013
    Innovation tied to globalization & collaboration

  • Virus Safety of Biopharmaceuticals

    Virus Safety of Biopharmaceuticals

    Hazel Aranha, Ph.D. || November 14, 2011
    Absence of evidence is not evidence of absence

  • Tocris Bioscience

    November 23, 2009

  • Concord Biotech Limited

    October 20, 2009

  • 2008 Top 10 Biopharmaceutical Companies Report

    2008 Top 10 Biopharmaceutical Companies Report

    July 18, 2008
    After years of producing this report, I’ve finally settled on definitive criteria for the Top Biopharma ranks! After consulting with Ronald A. Rader, president of the Biotechnology Information Institute, I decided that a Top Biopharma company is one that makes more than 40% of its drug revenues by selling biologic products, including biotherapeutics, vaccines and other proteins.